Intensity Therapeutics Files 8-K

Ticker: INTS · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1567264

Intensity Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyIntensity Therapeutics, Inc. (INTS)
Form Type8-K
Filed DateAug 4, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-k

TL;DR

INTENSITY THERAPEUTICS FILES 8-K - NO NEW MATERIAL INFO YET

AI Summary

Intensity Therapeutics, Inc. filed an 8-K on August 4, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material changes, but serves as a standard regulatory update.

Why It Matters

This 8-K filing indicates a routine regulatory update from Intensity Therapeutics, Inc. without disclosing new material information.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without disclosing specific material events or changes.

Key Players & Entities

  • INTENSITY THERAPEUTICS, INC. (company) — Registrant
  • August 4, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • 1 Enterprise Drive, Suite 430 Shelton, CT 06484 (address) — Principal Executive Offices

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The filing does not specify any 'Other Events' beyond the general categorization.

Are there any new financial statements or exhibits attached to this 8-K?

The filing lists 'Financial Statements and Exhibits' as an item, but the content of these is not detailed in the provided text.

Has Intensity Therapeutics, Inc. undergone any name changes recently?

The filing notes a former company name of 'Intensity Therapeutics, Inc.' with a date of name change as '20130117', indicating a past change.

What is the principal executive office address for Intensity Therapeutics, Inc.?

The principal executive offices are located at 1 Enterprise Drive, Suite 430, Shelton, CT 06484.

What is the SEC file number for Intensity Therapeutics, Inc.?

The SEC file number for Intensity Therapeutics, Inc. is 001-41109.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.